Journal Article
ADP as a novel stimulus for NLRP3-inflammasome activation in mice fails to translate to humans
Julius Wissemann; Adrian Heidenreich; Helene Zimmermann; Juliane Engelmann; Jasper Jansen; Dymphie Suchanek; Dirk Westermann; Dennis Wolf; Peter Stachon; Julian Merz
Purinergic Signalling · Vol. 20, Issue 3 · pp. 291-302 · 2024
Abstract
The NLRP3-inflammasome is a cytosolic multiprotein complex that triggers an inflammatory response to certain danger signals. Recently adenosine diphosphate (ADP) was found to activate the NLRP3-inflammasome in murine macrophages via the P2Y 1 receptor. Blockade of this signaling pathway reduced disease severity in a murine colitis-model. However, the role of the ADP/P2Y 1 -axis has not yet been studied in humans. This present study confirmed ADP-dependent NLRP3-inflammasome activation in murine macrophages, but found no evidence for a role of ADP in inflammasome activation in humans. We investigated the THP1 cell line as well as primary monocytes and further looked at macrophages. Although all cells express the three human ADP-receptors P2Y 1 , P2Y 12 and P2Y 13 , independent of priming, neither increased ASC-speck formation could be detected with flow cytometry nor additional IL-1β release be found in the culture supernatant of ADP stimulated cells. We now show for the first time that the responsiveness of monocytes and macrophages to ADP as well as the regulation of its purinergic receptors is very much dependent on the species. Therefore the signaling pathway found to contribute to colitis in mice is likely not applicable to humans.